Raymond James & Associates’s AdaptHealth AHCO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $225K | Buy |
20,002
+64
| +0.3% | +$719 | ﹤0.01% | 3542 |
|
|
2024
Q2 | $199K | Buy |
19,938
+3,959
| +25% | +$39.6K | ﹤0.01% | 3572 |
|
|
2024
Q1 | $184K | Buy |
15,979
+194
| +1% | +$2.23K | ﹤0.01% | 3605 |
|
|
2023
Q4 | $115K | Buy |
15,785
+4,740
| +43% | +$34.6K | ﹤0.01% | 3596 |
|
|
2023
Q3 | $101K | Buy |
+11,045
| New | +$101K | ﹤0.01% | 3567 |
|
|
2022
Q2 | – | Sell |
-57,110
| Closed | -$915K | – | 3849 |
|
|
2022
Q1 | $915K | Buy |
57,110
+37,271
| +188% | +$597K | ﹤0.01% | 2653 |
|
|
2021
Q4 | $485K | Buy |
19,839
+85
| +0.4% | +$2.08K | ﹤0.01% | 3088 |
|
|
2021
Q3 | $460K | Buy |
+19,754
| New | +$460K | ﹤0.01% | 3112 |
|
|
2021
Q2 | – | Sell |
-12,630
| Closed | -$464K | – | 3902 |
|
|
2021
Q1 | $464K | Buy |
+12,630
| New | +$464K | ﹤0.01% | 3055 |
|